Skip to main content
Equibles
EVAX logo

EVAX · Evaxion A/S

Track EVAX — free

Use EVAX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about EVAX

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$3.34 +0.13 (+4.02%) At close · Aug 14
Market Cap
$27.86M
Shares
8.34M

Evaxion A/S Earnings Call Transcripts

Every quarterly earnings call for Evaxion A/S (EVAX) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY26 · Q2
2026-08-20
Earnings conference call (announced in 6-K)
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-03-31
Evaxion A/S Q1 FY2026 Earnings Call
Positive tone EVX-01 melanoma Phase II program AI-Immunology platform expansion Business development and partnering
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-12-31
Evaxion A/S Q4 FY2025 Earnings Call
Confident tone AI immunology platform expansion into autoimmune disease Business development and MSD partnership EVX-01 personalized cancer vaccine Phase II data
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Evaxion A/S Q3 FY2025 Earnings Call
Confident tone EVX-01 Phase II clinical data (ESMO) MSD partnership and EVX-B3 in-licensing Leadership transition
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Evaxion A/S Q2 FY2025 Earnings Call
Positive tone EVX-01 Phase II melanoma program Infectious disease pipeline expansion EIB loan conversion to equity
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Evaxion A/S Q1 FY2025 Earnings Call
Confident tone EVX-01 clinical program Business development and partnerships Financial results and derivatives
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
Evaxion A/S Q2 FY2024 Earnings Call
Confident tone EVX-01 Phase 2 in melanoma Pipeline and upcoming milestones Business development and partnerships
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Evaxion A/S Q4 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q2
2023-06-30
Evaxion A/S Q2 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Evaxion A/S Q4 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q2
2022-06-30
Evaxion A/S Q2 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Evaxion A/S Q1 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Evaxion A/S Q4 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q1
2021-03-31
Evaxion A/S Q1 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–14 of 14 earnings calls
Key facts CIK 1828253 CUSIP 29970R303 13F (30d) 19 filings 19 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)